[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer

Radiotherapy and Oncology

Volumn 79, Issue 3, 2006, Pages 249-258

  Vanderstraeten, Barbara ^a,b   Duthoy, Wim ^a   Gersem, Werner De ^a   Neve, Wilfried De ^a   Thierens, Hubert ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

18F FDG PET; Head and neck cancer; IMRT; Optimization; Voxel intensity

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; FEASIBILITY STUDY; HEAD AND NECK TUMOR; METHODOLOGY; PHASE 1 CLINICAL TRIAL; RADIATION RESPONSE; SCINTISCANNING;

DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 33746237590     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.003     Document Type: Article

References (47)

1. 18F]Fluoro-2-Deoxy-d-Glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
2. 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67 (2003) 339-344
3. Burgman P., O'Donoghue J.A., Humm J.L., and Ling C.C. Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med 42 (2001) 170-175
4. Bussels B., Maes A., Hermans R., Nuyts S., Weltens C., and Van den Bogaert W. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
5. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer. Radiother Oncol 73 (2004) 289-296
6. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumour resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
7. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
8. Claus F., De Gersem W., De Wagter C., et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int J Radiat Oncol Biol Phys 51 (2001) 318-331
9. Clavo A.C., Brown R.S., and Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36 (1995) 1625-1632
10. Clavo A.C., and Wahl R.L. Effects of hypoxia on the uptake of tritiated thymidine, l-leucine, l-methionine, and FDG in cultured cancer cells. J Nucl Med 37 (1996) 502-506
11. Daisne J.F., Sibomana M., Bol A., Cosnard G., Lonneux M., and Grégoire V. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. Radiother Oncol 69 (2003) 237-245
12. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., and Grégoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
13. Daisne J.F., Duprez T., Weynand B., et al. Tumour volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR Imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
14. Das S.K., Miften M.M., Zhou S., et al. Feasibility of optimizing the dose distribution in lung tumours using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys 31 (2004) 1452-1461
15. Dawson L., Anzai Y., Marsh L., et al. Patterns of loco-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
16. Dearling J.L., Flynn A.A., Sutcliffe-Goulden J., et al. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. J Nucl Med 45 (2004) 101-107
17. De Gersem W., Claus F., De Wagter C., and De Neve W. An anatomy-based beam segmentation tool for intensity-modulated radiation therapy and its application to head-and-neck cancer. Int J Radiat Oncol Biol Phys 51 (2001) 849-859
18. De Gersem W., Claus F., De Wagter C., Van Duyse B., and De Neve W. Leaf position optimization for step-and-shoot IMRT. Int J Radiat Oncol Biol Phys 51 (2001) 1371-1388
19. De Neve W., and Duthoy W. Intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 4 (2004) 425-434
20. De Neve W., Wu Y., and Ezzell G. Practical IMRT planning. In: Bortfeld T., Schmidt-Ullrich R., De Neve W., and Wazer D.E. (Eds). Image-Guided IMRT (2006), Springer, Berlin 49-54
21. DeNittis A.S., Liu L., Rosenthal D.I., and Machtay M. Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy and concurrent/adjuvant chemotherapy. Am J Clin Oncol 25 (2002) 93-95
22. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combinded PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 77 (2005) 5-10
23. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., and Ship J.A. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
24. Eisbruch A., Foote R., O'Sullivan B., Beitler J.J., and Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12 (2002) 238-249
25. Feng M., Jabbari S., Lin A., et al. Predictive factors of loco-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol 77 (2005) 32-38
26. Geets X., Daisne J.F., Grégoire V., Hamoir M., and Lonneux M. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 71 (2004) 267-273
27. Grégoire V., Coche E., Cosnard G., Hamoir M., and Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
28. Grégoire V. Is there any future in radiotherapy planning without the use of PET: unraveling the myth. Radiother Oncol 73 (2004) 261-263
29. Harnsberger H.R., and Willey R.C. Handbook of head and neck imaging. 2nd ed (1995), Mosby, St Louis, MO
30. Holloway C.L., Robinson D., Murray B., et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73 (2004) 285-287
31. Kitagawa Y., Sano K., Nishizawa S., et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med 30 (2003) 63-71
32. Lavrenkov K., Partridge M., Cook G., and Brada M. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 77 (2005) 1-4
33. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
34. 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Radiother Oncol 73 (2004) 277-283
35. Ling C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
36. Longobardi B., De Martin E., Fiorino C., et al. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Radiother Oncol 77 (2005) 148-156
37. Miles E.A., Clark C.H., Guerrero Urbano M.T., et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 77 (2005) 241-246
38. Mohan R., Wu Q., Manning M., and Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46 (2000) 619-630
39. Pugachev A., Ruan S., Carlin S., et al. Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62 (2005) 545-553
40. Rajendran J.G., Mankoff D.A., O'Sullivan F., et al. Hypoxia and glucose metabolism in malignant tumors. Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10 (2004) 2245-2252
41. Rudoltz M.S., Perkins R.S., Luthmann R.W., et al. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx. Laryngoscope 109 (1999) 1967-1973
42. Saarilahti K., Kouri M., Collan J., et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
43. Tate D.J., Adler J.R., Chang S.D., et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys 45 (1999) 915-921
44. Van de Wiele C., Lahorte C., Oyen W., et al. Nuclear medicine imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys 55 (2003) 5-15
45. Vrieze O., Haustermans K., De Wever W., et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol 73 (2004) 269-275
46. Wu Q., Mohan R., Morris M., Lauve A., and Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 56 (2003) 573-585
47. Zhao S., Kuge Y., Mochizuki T., et al. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46 (2005) 675-682